Ventripoint Diagnostics Ltd.

Stocks

VPT

CA92281P2008

Market Closed - Toronto S.E. 09:30:00 2026-10-29 EDT			5-day change	1st Jan Change
0.0800 ^CAD	-5.88%		-11.11%	-42.86%

10-09	Ventripoint Diagnostics Ltd. - Shareholder/Analyst Call
09-07	Ventripoint Diagnostics Ltd. announced that it expects to receive CAD 0.35 million in funding	CI

Transcript : Ventripoint Diagnostics Ltd. - Shareholder/Analyst Call

Published on 10/09/2026 at 03:05 pm EDT - Modified on 10/09/2026 at 03:50 pm EDT

S&P Capital IQ

Presenter Speech
Hugh MacNaught (Executives)

Well, good afternoon, everyone, and thank you for joining. My name is Hugh MacNaught, and I'm Ventripoint's President and CEO. During today's update, we'll

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about Ventripoint Diagnostics Ltd.

10-09	Ventripoint Diagnostics Ltd. - Shareholder/Analyst Call
09-07	Ventripoint Diagnostics Ltd. announced that it expects to receive CAD 0.35 million in funding	CI
09-01	Ventripoint Diagnostics Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-20	Unidoc Health Corp. Signs Mou with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform	CI
08-12	Ventripoint Diagnostics Ltd Expands Subscription Access For FDA-Cleared AI Cardiac Imaging Platform VMS+ 4.0	CI
08-05	UniDoc Health Corp. And Ventripoint Diagnostics Ltd. Sign MOU To Evaluate Scalable Remote Cardiac Assessment And Screening Platform	CI
07-29	Ventripoint Diagnostics Ltd. Announces the Appointment of Philip M. Toleikis to its Board of Directors	CI
07-20	Ventripoint Diagnostics Selects VMS+ Technology For Use In AIRES Clinical Research Study	CI
06-15	Ventripoint Diagnostics Ltd. and Global Congenital Heart Disease Alliance Announce Support for Global Congenital Heart Disease Alliance	CI
05-27	Ventripoint Diagnostics Ltd. - Shareholder/Analyst Call
05-21	Ventripoint Diagnostics Ltd. announced that it has received CAD 0.30803 million in funding	CI
05-01	Ventripoint Diagnostics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-30	Ventripoint Diagnostics Ltd. Auditor Raises 'Going Concern' Doubt	CI
04-28	Ventripoint Diagnostics Ltd. Announces Its Strategic Partner, Lishman Global Inc. Formally Submits Ventripoint's VMS+TM 4.0 System to China's National Medical Products Administration	CI
04-01	Ventripoint Diagnostics Ltd. and Health Division of the Montecristo Group Announce Collaboration to Explore Expanded Cardiac Screening, Clinical Research, and AI-Assisted Echocardiography in Costa Rica	CI

Chart Ventripoint Diagnostics Ltd.

Duration

Period

VPT: Dynamic Chart

Company Profile

Sector

More about the company

Income Statement and Estimates

Projected Income Statement - Annual - Ventripoint Diagnostics Ltd.

More financial data